title: Epidermal growth factor receptor (EGFR) inhibitory monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response.
authors.affiliation: Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Ommori
authors.affiliation: Department of Dermatology, Yamato Takada Municipal Hospital, Nara, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Park
authors.affiliation: Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
authors.forename: F
authors.initials: F
authors.lastname: Miyagawa
authors.affiliation: Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Azukizawa
authors.affiliation: Oncology Center, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kanno
authors.affiliation: Department of Dermatology, Nara Medical University, 840 Shijocho, Kashihara, Nara, 634-8522, Japan.
authors.forename: H
authors.identifier: 0000-0003-1971-9835
authors.initials: H
authors.lastname: Asada
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000068818:Cetuximab / Q000494:pharmacology*; D066246:ErbB Receptors / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects*; D015603:Keratinocytes / Q000276:immunology*; D000077544:Panitumumab / Q000494:pharmacology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D000077544:Panitumumab; C512478:EGFR protein, human; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases; D000068818:Cetuximab